Family hardships and serum cotinine in children with asthma

Adam J Spanier1, Andrew F Beck2, Bin Huang2

  • 1Department of Pediatrics, Penn State Milton S. Hershey Children's Hospital, Hershey, Pennsylvania; aspanier@peds.umaryland.edu.

Pediatrics
|January 14, 2015
PubMed

Insights

Family hardships significantly increase the risk of tobacco smoke exposure in children with asthma. Addressing these hardships may reduce health disparities and improve child health outcomes.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Health Disparities Research

Background:

  • Poverty-related hardships can negatively impact child health.
  • Tobacco smoke exposure is a potential consequence of family hardship.
  • Understanding this link can identify intervention targets for child health.

Purpose of the Study:

  • To investigate the association between family hardships and tobacco smoke exposure in children hospitalized for asthma.
  • To measure tobacco exposure using serum cotinine levels.

Main Methods:

  • Prospective cohort study of 774 children (1-16 years) hospitalized for asthma or wheezing.
  • Assessed 11 financial and social family hardships via caregiver survey.
  • Used logistic regression to analyze the relationship between hardships and detectable serum cotinine.

Main Results:

  • 56% of 675 children had detectable serum cotinine.
  • Over 80% of families reported at least one hardship; 41% reported four or more.
  • Families with ≥4 hardships had 3.7-fold higher odds of detectable cotinine; lower income and education were also associated.

Conclusions:

  • Family hardships are common among children with asthma and linked to tobacco smoke exposure.
  • Interventions targeting family hardships and tobacco smoke exposure could reduce health disparities.
  • This highlights potential strategies for improving health outcomes in vulnerable pediatric populations.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
3
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.7K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
16
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K